Glenmark Pharmaceuticals Limited header image

Glenmark Pharmaceuticals Limited

532296

Equity

ISIN INE935A01035 / Valor 3195888

Bombay Stock Exchange Ltd. (Mumbai) (2026-06-11)

INR 2,144.35+0.01%

Glenmark Pharmaceuticals Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Founded by Gracias Saldanha and headquartered at Glenmark House, B.D. Sawant Marg, Chakala, Andheri East, Mumbai, Glenmark Pharmaceuticals Limited is a research-led global pharmaceutical company. The company develops, manufactures and markets branded and generic formulations and APIs across dermatology, respiratory, oncology and other therapeutic segments. It operates in over 80 countries including the USA, Europe, India and emerging markets. A subsidiary Ichnos Sciences focuses on oncology biologic drug discovery. Glenn Saldanha serves as Chairman and MD.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

31.1%1Y

237%3Y

229%5Y

Performance

30.0%1Y

31.5%3Y

31.4%5Y

Volatility

6359 M

Market cap (USD)

9,124

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Teladoc Health Inc

Teladoc Health Inc Valor: 28438140

Annual Return

-50%0%+50%

Risk level

110

3.98%USD 7.31

Corcept Therapeutics Inc

Corcept Therapeutics Inc Valor: 1812837

Annual Return

-50%0%+50%

Risk level

110

6.57%USD 83.25

Dermapharm Holding SE

Dermapharm Holding SE Valor: 40166352

Annual Return

-50%0%+50%

Risk level

110

1.46%EUR 48.65

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co Valor: 914188

Annual Return

-50%0%+50%

Risk level

110

2.34%USD 56.90

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

1.99%USD 21.02

Xlife Sciences Ltd.

Xlife Sciences Ltd. Valor: 46192960

Annual Return

-50%0%+50%

Risk level

110

0.00%CHF 24.70

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Valor: 2791431

Annual Return

-50%0%+50%

Risk level

110

-0.33%CHF 12.06

UCB SA

UCB SA Valor: 986410

Annual Return

-50%0%+50%

Risk level

110

1.44%EUR 274.90

Intuitive Surgical Inc

Intuitive Surgical Inc Valor: 1631646

Annual Return

-50%0%+50%

Risk level

110

0.21%USD 412.90

Gyre Therapeutics Inc

Gyre Therapeutics Inc Valor: 130270397

Annual Return

-50%0%+50%

Risk level

110

1.85%USD 6.06

SIX

FactSet

Clearbit

Logos provided by Clearbit